144 related articles for article (PubMed ID: 34324432)
1. Prevalence and risk factors of hypothalamic-pituitary dysfunction in infant and toddler childhood brain tumor survivors.
Lebbink CA; Ringers TP; Schouten-van Meeteren AYN; van Iersel L; Clement SC; Boot AM; Claahsen-van der Grinten HL; Janssens GO; van Vuurden DG; Michiels EM; Han KS; van Trotsenburg ASP; Vandertop WP; Kremer LCM; van Santen HM
Eur J Endocrinol; 2021 Sep; 185(4):597-606. PubMed ID: 34324432
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of Weight Gain in Childhood Brain Tumor Survivors and Its Association With Hypothalamic-Pituitary Dysfunction.
van Schaik J; van Roessel IMAA; Schouten-van Meeteren NAYN; van Iersel L; Clement SC; Boot AM; Claahsen-van der Grinten HL; Fiocco M; Janssens GO; van Vuurden DG; Michiels EM; Han SKS; van Trotsenburg PASP; Vandertop PWP; Kremer LCM; van Santen HM
J Clin Oncol; 2021 Apr; 39(11):1264-1273. PubMed ID: 33621126
[TBL] [Abstract][Full Text] [Related]
3. Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.
van Iersel L; Li Z; Srivastava DK; Brinkman TM; Bjornard KL; Wilson CL; Green DM; Merchant TE; Pui CH; Howell RM; Smith SA; Armstrong GT; Hudson MM; Robison LL; Ness KK; Gajjar A; Krull KR; Sklar CA; van Santen HM; Chemaitilly W
J Clin Endocrinol Metab; 2019 Dec; 104(12):6101-6115. PubMed ID: 31373627
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.
Clement SC; Schouten-van Meeteren AY; Boot AM; Claahsen-van der Grinten HL; Granzen B; Sen Han K; Janssens GO; Michiels EM; van Trotsenburg AS; Vandertop WP; van Vuurden DG; Kremer LC; Caron HN; van Santen HM
J Clin Oncol; 2016 Dec; 34(36):4362-4370. PubMed ID: 27998218
[TBL] [Abstract][Full Text] [Related]
5. High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs.
Clement SC; Meeteren AY; Kremer LC; van Trotsenburg AS; Caron HN; van Santen HM
Pediatr Blood Cancer; 2014 Dec; 61(12):2285-9. PubMed ID: 25131941
[TBL] [Abstract][Full Text] [Related]
6. Body mass index at diagnosis of a childhood brain tumor; a reflection of hypothalamic-pituitary dysfunction or lifestyle?
van Roessel IMAA; van Schaik J; Meeteren AYNS; Boot AM; der Grinten HLC; Clement SC; van Iersel L; Han KS; van Trotsenburg ASP; Vandertop WP; Kremer LCM; van Santen HM
Support Care Cancer; 2022 Jul; 30(7):6093-6102. PubMed ID: 35416504
[TBL] [Abstract][Full Text] [Related]
7. Hypothalamic-pituitary dysfunction in survivors of childhood brain tumors in Prasat Neurological Institute.
Lusawat A; Dhiravibulya K; Thammongkol S; Vanavanan S; Mahachoklertwattana P
J Med Assoc Thai; 2010 Jan; 93(1):38-47. PubMed ID: 20196409
[TBL] [Abstract][Full Text] [Related]
8. Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.
Clement SC; Schoot RA; Slater O; Chisholm JC; Abela C; Balm AJM; van den Brekel MW; Breunis WB; Chang YC; Davila Fajardo R; Dunaway D; Gajdosova E; Gaze MN; Gupta S; Hartley B; Kremer LCM; van Lennep M; Levitt GA; Mandeville HC; Pieters BR; Saeed P; Smeele LE; Strackee SD; Ronckers CM; Caron HN; van Santen HM; Merks JHM
Eur J Cancer; 2016 Feb; 54():1-10. PubMed ID: 26707591
[TBL] [Abstract][Full Text] [Related]
9. Hypothalamic-Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline.
Sklar CA; Antal Z; Chemaitilly W; Cohen LE; Follin C; Meacham LR; Murad MH
J Clin Endocrinol Metab; 2018 Aug; 103(8):2761-2784. PubMed ID: 29982476
[TBL] [Abstract][Full Text] [Related]
10. Antibodies Against Hypothalamus and Pituitary Gland in Childhood-Onset Brain Tumors and Pituitary Dysfunction.
Patti G; Calandra E; De Bellis A; Gallizia A; Crocco M; Napoli F; Allegri AME; Thiabat HF; Bellastella G; Maiorino MI; Garrè ML; Parodi S; Maghnie M; di Iorgi N
Front Endocrinol (Lausanne); 2020; 11():16. PubMed ID: 32132974
[No Abstract] [Full Text] [Related]
11. Methylphenidate improves weight control in childhood brain tumor survivors with hypothalamic obesity.
Horne VE; Bielamowicz K; Nguyen J; Hilsenbeck S; Lindsay H; Sonabend R; Wood AC; Okcu F; Sisley S
Pediatr Blood Cancer; 2020 Jul; 67(7):e28379. PubMed ID: 32383818
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of hypothalamic-pituitary disorders after conformal radiation therapy for pediatric low-grade glioma or ependymoma.
van Iersel L; van Santen HM; Potter B; Li Z; Conklin HM; Zhang H; Chemaitilly W; Merchant TE
Pediatr Blood Cancer; 2020 Dec; 67(12):e28723. PubMed ID: 33037871
[TBL] [Abstract][Full Text] [Related]
13. Endocrine Disorders in Childhood Brain Tumour Survivors: A Single-Centre Study.
Ramezan NW; Hussain S; Mohamad N; Yaacob NM
J ASEAN Fed Endocr Soc; 2024; 39(1):12-17. PubMed ID: 38863912
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients.
Maciel J; Dias D; Cavaco D; Donato S; Pereira MC; Simões-Pereira J
J Endocrinol Invest; 2021 Nov; 44(11):2367-2374. PubMed ID: 33683662
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Endocrine Disorders in Childhood Brain Tumor Survivors in South Korea.
Heo J; Lee HS; Hwang JS; Noh OK; Kim L; Park JE
In Vivo; 2019; 33(6):2287-2291. PubMed ID: 31662569
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamic dysfunction after chemotherapy.
Rose SR; Schreiber RE; Kearney NS; Lustig RH; Danish RK; Burghen GA; Hudson MM
J Pediatr Endocrinol Metab; 2004 Jan; 17(1):55-66. PubMed ID: 14960022
[TBL] [Abstract][Full Text] [Related]
17. Pituitary disease in pediatric brain tumor survivors.
Howell JC; Rose SR
Expert Rev Endocrinol Metab; 2019 Jul; 14(4):283-291. PubMed ID: 31131647
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of fibromyalgia-associated symptoms in patients with hypothalamic-pituitary disorders.
Harbeck B; Süfke S; Harten P; Haas CS; Lehnert H; Mönig H
Clin Exp Rheumatol; 2013; 31(6 Suppl 79):S16-21. PubMed ID: 23981240
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors.
van Iersel L; Mulder RL; Denzer C; Cohen LE; Spoudeas HA; Meacham LR; Sugden E; Schouten-van Meeteren AYN; Hoving EW; Packer RJ; Armstrong GT; Mostoufi-Moab S; Stades AM; van Vuurden D; Janssens GO; Thomas-Teinturier C; Murray RD; Di Iorgi N; Neggers SJCMM; Thompson J; Toogood AA; Gleeson H; Follin C; Bardi E; Torno L; Patterson B; Morsellino V; Sommer G; Clement SC; Srivastava D; Kiserud CE; Fernandez A; Scheinemann K; Raman S; Yuen KCJ; Wallace WH; Constine LS; Skinner R; Hudson MM; Kremer LCM; Chemaitilly W; van Santen HM
Endocr Rev; 2022 Sep; 43(5):794-823. PubMed ID: 34962573
[TBL] [Abstract][Full Text] [Related]
20. DIAGNOSING AND MONITORING ENDOCRINE DYSFUNCTION, DIABETES, AND OBESITY IN A COHORT OF ADULT SURVIVORS OF CHILDHOOD CANCER.
Hudspeth VR; Gold SH; Clemmons DR
Endocr Pract; 2017 Dec; 23(12):1394-1401. PubMed ID: 29144813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
